Comparison

CH-223191 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Clone N/A
Amount 100 mg
Item no. HY-12684-100mg
Targets Aryl Hydrocarbon Receptor
CASRN 301326-22-7
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
CH-223191 is a potent and specific antagonist of aryl hydrocarbon receptor (AhR).
CH-223191 inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and inhibits TCDD-induced luciferase activity with an IC50 of 0.03 μM[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
Cancer-programmed cell death
MolecularWeight
333.39
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Manufacturers Target
Aryl Hydrocarbon Receptor
Pathway
Immunology/Inflammation
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close